TABLE 2.

Treatment-Emergent Adverse Events Reported by Patients Receiving Atomoxetine or Placebo*

EventAtomoxetine (n = 31) (%)Placebo (n = 21) (%)
Rhinitis25.838.1
Abdominal pain29.014.3
Headache25.814.3
Pharyngitis19.419.0
Decreased appetite19.419.0
Vomiting19.40.0
Cough increased16.14.8
Nervousness6.514.3
Somnolence6.514.3
Nausea6.514.3
Emotional lability3.214.3
Fever9.74.8
Insomnia3.29.5
Diarrhea3.24.8
Dizziness3.24.8
  • * There were no statistically significant differences between treatment groups.